Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

Share Price is delayed by 15 minutes
Get Live Data
674.00    -2.00 (-0.30%)
Bid:
670.00
Ask:
678.00
Spread: 8.00 (1.194%)
Market Cap: £334.05m
ELIX Live PriceLast checked at - London Stock Exchange

Intraday Elixirr International Share Chart

Investor Presentation

1 Oct 2024 07:00

RNS Number : 3322G
Elixirr International PLC
01 October 2024
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Investor Presentation via Investor Meet Company

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, is pleased to announce that Stephen Newton (CEO), Graham Busby (CFO), Nick Willott (Finance Director) and Emiko Caerlewy-Smith (Partner) will provide a live presentation in relation to the Company's Interim Results via the Investor Meet Company platform on 09 October 2024 at 12:00 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 09:00 BST on 07 Oct 2024, or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet ELIXIRR INTERNATIONAL PLC via:

 

https://www.investormeetcompany.com/elixirr-international-plc/register-investor

 

Investors who already follow Elixirr International plc on the Investor Meet Company platform will automatically be invited.

 

For further information please contact:

Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO

 

 +44 (0) 20 7220 5410

 

Public and Investor Relations contacts:

investor-relations@elixirr.com 

 

Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker)

Stephen Keys, Callum Davidson (Corporate Finance)

Sunila De Silva (ECM)

 

Investec Bank plc (Joint Broker)

Carlton Nelson, Henry Reast (Corporate Broking)

 

 

 

 

+44 (0) 20 7220 0500

 

 

+44 (0) 20 7597 4000

 

About Elixirr International plc

Elixirr is an award-winning global consulting firm working with clients across a diverse range of industries, markets and geographies.

Founded in 2009, the firm set out to be the 'challenger consultancy' and do things differently than the large corporate consultancies dominating the industry: working openly and collaboratively with clients from start to finish, delivering outcomes based on innovative thinking, not methodology, and treating each client's business like their own. Elixirr has been quoted on the AIM market of the London Stock Exchange since 2020. In addition to strong organic growth, Elixirr has acquired six boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP, Responsum and Insigniam - to grow the Group's capabilities, diversify the business, expand into new geographies and access new clients.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUWCBUPCGQU
Date   Source Headline
25th Nov 20247:00 amRNSChange of Adviser
31st Oct 20247:00 amRNSPDMR Dealings
25th Oct 202412:01 pmRNSDirector/PDMR Shareholding
25th Oct 20247:00 amRNSResult of Secondary Placing
24th Oct 20244:35 pmRNSProposed Secondary Placing
21st Oct 20247:00 amRNSAcquisition of Hypothesis Group, LLC
14th Oct 20247:00 amRNSRevolving Credit Facility
1st Oct 20247:00 amRNSInvestor Presentation
23rd Sep 20247:00 amRNSInterim Results
31st Jul 20245:00 pmRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSPDMR/PCA Dealings
12th Jul 20244:15 pmRNSDirector/PDMR Shareholding
9th Jul 202411:45 amRNSPurchase of Shares by Employee Benefit Trust
3rd Jul 202410:30 amRNSDirector Dealing
25th Jun 20249:55 amRNSResult of AGM
31st May 20247:00 amRNSPosting of Annual Report and Accounts
21st May 20246:20 pmRNSDirector Declaration
24th Apr 20247:00 amRNSGrant of Share Options
22nd Apr 20247:00 amRNSFinal Results
8th Apr 20247:00 amRNSNotice of FY 23 Results and Investor Presentation
26th Jan 20247:00 amRNSDirector Dealing
8th Jan 20247:00 amRNSTrading Update and Change to Dividend Policy
11th Dec 20237:00 amRNSAcquisition of Insigniam LLC and Insigniam SAS
18th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSAcquisition of Responsum, Inc.
13th Jun 202310:45 amRNSResult of AGM
24th May 20231:31 pmRNSHolding(s) in Company
19th May 20237:00 amRNSPosting of Annual Report and Accounts
10th May 20233:00 pmRNSDirector/PCA Dealings
26th Apr 20237:00 amRNSGrant of Share Options
12th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20233:00 pmRNSDirector Dealing
3rd Apr 20239:15 amRNSDirector Dealing
3rd Apr 20237:00 amRNSFinal Results
28th Mar 20237:00 amRNSInvestor Presentation
27th Feb 20239:05 amRNSSecond Price Monitoring Extn
27th Feb 20239:00 amRNSPrice Monitoring Extension
27th Feb 20237:00 amRNSTrading Update
24th Feb 20232:05 pmRNSSecond Price Monitoring Extn
24th Feb 20232:00 pmRNSPrice Monitoring Extension
24th Feb 202311:05 amRNSSecond Price Monitoring Extn
24th Feb 202311:00 amRNSPrice Monitoring Extension
29th Nov 20221:15 pmRNSInvestor Presentation
11th Nov 20227:00 amRNSDirector Dealing
20th Oct 20227:00 amRNSPCA Dealing
6th Oct 20227:00 amRNSPurchase of Shares by Employee Benefit Trust
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.